Enhancing the science in the global fight to end HIV

The kit enables reliable genotyping of HIV-1 from human EDTA plasma and dried blood spot (DBS) samples to detect resistance to protease, nucleoside reverse-transcriptase, non-nucleoside reverse-transcriptase, and integrase inhibitors

New HIV-1 Genotyping Kit with Integrase workflow

Enabling solutions to follow WHO testing recommendations

The World Health Organization (WHO) recommends that HIV drug resistance prevention,
monitoring, and response be integrated into every national HIV program and into routine
cascade data review activities.* With the adoption of integrase inhibitor treatment,
monitoring of drug resistance is critical to establish a baseline and to proactively prevent
unnecessary emergence and transmission of HIV

The HIV-1 Genotyping kit with Integrase helps to address the needs of resource-limited settings

Request for More Info